Isofol Medical AB (OSTO:ISOFOL) Accounts Payable & Accrued Expense : kr1.78 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Isofol Medical AB Accounts Payable & Accrued Expense?

Isofol Medical AB's quarterly accounts payable & accrued expense declined from Sep. 2023 (kr2.57 Mil) to Dec. 2023 (kr1.99 Mil) and declined from Dec. 2023 (kr1.99 Mil) to Mar. 2024 (kr1.78 Mil).

Isofol Medical AB's annual accounts payable & accrued expense declined from Dec. 2021 (kr17.74 Mil) to Dec. 2022 (kr7.87 Mil) and declined from Dec. 2022 (kr7.87 Mil) to Dec. 2023 (kr1.99 Mil).

Isofol Medical AB Accounts Payable & Accrued Expense Historical Data

The historical data trend for Isofol Medical AB's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Isofol Medical AB Accounts Payable & Accrued Expense Chart

Isofol Medical AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

10.25

20.89

17.74

7.87

1.99

Isofol Medical AB Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															2.90	1.99	2.57	1.99	1.78

Isofol Medical AB Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Isofol Medical AB (OSTO:ISOFOL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Isofol Medical AB (OSTO:ISOFOL) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

5IU:Germany

Address

Arvid Wallgrens Backe 20, Biotech Center, Gothenburg, SWE, SE-413 46

Website

http://www.isofol.se

Isofol Medical AB is a pharmaceutical company. It is a manufacturer of folate-based therapies. The company's drug candidate Modufolin enhances the effect of the current chemotherapy treatment for patients treated for colorectal cancer. Its products are used to increase efficacy and reduce the side effects of antimetabolite cancer treatment.

Isofol Medical AB (OSTO:ISOFOL) Headlines

No Headlines